Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Search clinical trials for: Vamorolone 0.75 mg/day/day
Total 0 results
Nothing found
Sponsors and Collaborators
Stefano Rizza
WillowWood Global LLC
Pedro Rodrigues Genta
Hoffmann-La Roche
delta medical promotions ag
Peijas Hospital
Marealis AS
the Regional Direction of Clinical Research
mHealth Impact Lab
Washington State Attorney General's Office
London Metropolitan University
IRCCS San Raffaele Roma
Dermatologic Surgery Center of Washington LLC and Skin Cancer Treatment Center
HMO Gesundheitsplan Basel, Switzerland
Universidad de Chile (UChile, Chile)
Advanced Reconstructive Surgery Alliance
Hangzhou Neoantigen Therapeutics Co., Ltd.
Center for HIV/AIDS Vaccine Immunology
Nuseed Americas Inc.
Gynea Laboratorios SA
View Full List
Medical Conditions
Survivors of Childhood Cancer
Unrestricted Arm Movement
PURPURA
Urinary System Stones
Hermansky Pudlak Syndrome
Hyperthyroid
Midgut Carcinoid Tumor
Amniotic Fluid Leakage
Non-Hodgkin's Lymphoma (NHL) or Hodgkin's Disease (HD) in 2nd or Greater Complete Remission, Partial Remission
CHD - Coronary Heart Disease
Urosepsis
Hyperhidrosis Primary Focal Axilla
Tonsil Disease
Cervical Spondylotic Myelopathy
ERYTHROCYTOSIS
Charcot-Marie-Tooth Disease Type 2U (Diagnosis)
Pancreatic Carcinoma; Lipoprotein a; Overall Survival; Prognosis
Apgar; 0-3 at 1 Minute
Flatulence
Varicocele Grade III
View Full List
Drug Interventions
Ibrutinib
Active Comparator: TU2670 320mg
Fosinopril sodium and hydrochlorothiazide 20-12.5 mg tablets
Basiliximab
Immediate-release nicotinamide (SAD)
Yohimbine hydrochloride
Simvastatin
BIC/FTC/TAF
Metronidazole
Rituxumab
Vincristine
MP0317, a tri-specific fibroblast activation protein (FAP) x CD40 DARPin® drug candidate (q1w regimen)
Atorvastatin
Delamanid
Amivantamab
Bictegravir (BIC) plus Emtricitabine (FTC) plus Tenofovir Alafenamide (TAF)
Etoposide
Silymarin (Silybum marianum)
Neridronate
RhGM-CSF
View Full List
CROs by country
Contract Research Organizations in Azerbaijan
Contract Research Organizations in Czech Republic
Contract Research Organizations in Equatorial Guinea
Contract Research Organizations in Guinea
Contract Research Organizations in Ireland
Contract Research Organizations in Jamaica
Contract Research Organizations in Kazakhstan
Contract Research Organizations in Malawi
Contract Research Organizations in Mongolia
Contract Research Organizations in Senegal
Contract Research Organizations in Suriname
Contract Research Organizations in Tanzania
Contract Research Organizations in Vietnam
CRO list by country
CROs in Guatemala
SGS
PRA Health Sciences
ICON
All CROs in Guatemala
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe